THE ERA OF

GENETIC NEUROSCIENCE
HAS ARRIVED

The field of neurology has been primed for a revolution in how new therapies are discovered. We have taken the charge to develop them.

The needs of patients with CNS disorders are devastatingly urgent. Our mission is to help patients by delivering life-altering treatments faster and more effectively than has ever been done before - and to do it again and again.

OUR PURPOSE

The reason we come to work everyday is because of little men like this.

Collin — 4 years old. Suffers from Epilepsy

ABOUT US

Praxis is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for patients affected by central nervous system (“CNS”) disorders characterized by neuronal imbalance

What is Praxis?

At Praxis we get things done. Praxis is the process of using a theory or something that you have learned in a practical way. It is a mindset that allows us to simplify the complex and independently define a solution without being restricted by predefined processes.

OUR APPROACH

Each of our programs is based on four key principles that we believe will both increase the probability of success and allow us to efficiently translate insights into high-impact therapies for patients and society:

01
Focus on therapeutic targets identified through human genetics.
02
Utilize translational tools to validate the potential of our targets and product candidates.
03
Pursue efficient, rigorous clinical development paths to proof-of-concept in humans.
04
Apply patient-centric development strategies.

Inspired by breakthroughs in the genetics of epilepsy, focused on rare genetic epilepsies and more common CNS disorders

CURRENT DEVELOPMENT PIPELINE

LEADERSHIP TEAM

We have attracted a talented team of scientists and researchers in genetics and biology, chemistry and translational medicine as well as business leaders with established track records of successfully executing innovative drug discovery and development programs.

Scientific Founders

Kiran Reddy, M.D.Co-founder, Praxis Medicines, Member of the Board, Managing Director at Blackstone Lifesciences
David Goldstein, Ph.D.Co-founder, Praxis Medicines, Director of The Institute for Genomic Medicine, and Professor in the Department of Genetics and Development, at Columbia University
Steven Petrou, Ph.D.Co-founder, Chief Scientific Officer, Praxis Medicines, Director of the Florey Institute of Neuroscience and Mental Health, Head of the Department of the Florey Institute at the University of Melbourne in Australia

CAREERS

We are a values-driven organization focused on our people and centered around trust, ownership, curiosity and results.

Company culture is everything

Our culture defines how we work – agnostic to the source of an idea, we work together to find the most practical solutions for patients as quickly and efficiently as possible.

Our sights are set big

We share a common vision of reshaping the human condition into a more freeing and fulfilled existence by developing high impact medicines for patients and families affected by and living with complex brain disorders.

JOIN US ON OUR MISSION.

Email resumes to [email protected]

CONTACT US

Cambridge, Massachusetts
*Please complete all fields correctly